title: Recognizing neuroleptic malignant syndrome.
authors.forename: Patricia I
authors.initials: PI
authors.lastname: Rosebush
authors.forename: Sarah
authors.initials: S
authors.lastname: Garside
authors.forename: Michael F
authors.initials: MF
authors.lastname: Mazurek
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D003402:Creatine Kinase / Q000378:metabolism; D018492:Dopamine Antagonists / Q000009:adverse effects* / Q000494:pharmacology; D065127:Dopamine D2 Receptor Antagonists; D006220:Haloperidol / Q000031:analogs & derivatives*; D006801:Humans; D008297:Male; D009459:Neuroleptic Malignant Syndrome / Q000209:etiology*
chemical_list: D018492:Dopamine Antagonists; D065127:Dopamine D2 Receptor Antagonists; D003402:Creatine Kinase; D006220:Haloperidol